Dr. John Cush

rheumnow.bsky.social

05 June 2025 22:25

Target emulation trial w/ data from British Dermatologists Biologics & Immunomodulators Register, studied 231 PSO Rx w/ MTX + Adalimumab against 1553 PSO on ADA. @1Yr MTX did not augment ADA only responses based on Rx survival (79% vs 78%) or PASI75 (49% vs 52%). jamanetwork.com/journals/jam...

Steven Chen, MD MPH MS-HPEd

drsteventchen.bsky.social

27 March 2025 22:31

Yes! I’m starting to use it and hoping it’s a game changer

Simpson Lab at UW

simpsonlabuw.bsky.social

27 March 2025 22:31

Love that JAKi is now on the list for SJS based on recent data…really hoping that pans out. They seem to work for everything else in derm😉 Also may work for idiopathic EM based on work from Yale. Just makes sense that an aberrantly activated anti-viral pathway may be to blame for some of these rxns.

Amy Paller, MD

pallerlab.bsky.social

11 March 2025 13:37

Great to be at #AAD2025, sharing our lab’s work and connecting with colleagues in the field. Exciting discussions and a fantastic meeting! Science drives innovation, informs policy, and improves lives—let’s continue to champion its role in society. #StandUpForScience @aadmember.bsky.social

Misha Rosenbach, MD

misharosenbach.bsky.social

11 March 2025 13:36

@roxanadaneshjou.bsky.social @drsteventchen.bsky.social @drjohnbarbieri.bsky.social I will know #DermSky has made it when we have an #AAD2025 starter pack and are discussing/posting/actually eating crickets as sustainable food.